“Biomedical Perspective on OnabotulinumtoxinA: Efficacy and Clinical Management in Chronic Migraine Treatment”. 2026. Research, Society and Development 15 (5): e1215551006. https://doi.org/10.33448/rsd-v15i5.51006.